The Indian Pharma Companies has emerged as a strong generic player since the Indian Patent Act has been introduced in 1970. Earlier only process patents are allowed but from 2005 onwards India has shifted towards the product patent regime which has put the industry on a new growth trajectory. There are immense opportunities for [...]
Yahoo! Inc. is an American multinational internet corporation headquartered in Sunnyvale, California, United States. It is one of the largest websites in the United States. Since 1994 Yahoo! has grown to become a premiere digital media and communications company. With time Yahoo! Has diversified its product offerings beyond its original directory of websites. For [...]
As reported yesterday, Indian companies have started growing and maturing in terms of monetizing their intellectual property. Tata Steel which spends 1.5 % of total revenue in research and development is contemplating to earn money by licensing its intellectual property to other steel companies. At moment, Tata Steel is the world's seventh largest steel [...]
As reported by Mint, Biocon revenue up 16% but profit hit by loss of licensing. Licensing is surely important source of revenue generation. Biocon’s net profit has declined which is due to loss of licensing income from Pfizer, Divestment of Axicorp stake and licensing income from other partners such as Mylan Inc. Biocon and [...]
Facebook is preparing for its May IPO and has spent money billion so far in buying patents from IBM, Instagram and now Microsoft. Microsoft Corporation and Facebook announced an agreement under which Facebook has agreed to purchase patents which Microsoft has recently bought for AOL for $550 million in cash. As per agreement, Facebook [...]
On 26th April 2012, we wish all readers happy and innovative “World IP Day”. Keeping the spirit of “visionary innovators” IIPTA has conducted series of IP workshops across various pharmaceutical and biotechnology colleges in India. Main aim of the workshop was to make students – the future innovators aware about intellectual property. [...]
